|
[1]MURAKAMI Y, TOYODA H, TANAHASHI T, et al.Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease[J].PLoS One, 2012, 7 (10) :e48366.
|
|
[2]LI C, WAN MB, WANG HF.Research progress on microRNA in the HBV-related liver disease[J].Chin J Gastroenterol Hepatol, 2010, 19 (8) :2371-2373. (in Chinese) 李晨, 万谟彬, 王慧芬.microRNA在HBV相关肝病中的研究进展[J].胃肠病学和肝病学杂, 2010, 19 (8) :2371-2373.
|
|
[3]JI F, YANG B, PENG X, et al.Circulating microRNAs in hepatitis B virus-infected patients[J].J Viral Hepat, 2011, 18 (7) :e242-e251.
|
|
[4] QIU L, FAN H, JIN W, et al.miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV[J].Biochem Biophys Res Commun, 2010, 398 (4) :771-777.
|
|
[5]SHWETHA S, GOUTHAMCHANDRA K, CHANDRA M, et al.Circulating miRNA profile in HCV infected serum:novel insight into pathogenesis[J].Sci Rep, 2013, 3:1555.
|
|
[6]ARZUMANYAN A, REIS HM, FEITELSON MA.Pathogenic mechanism in HBV and HCV-associated hepato-cellular carcinom[J]Nat Rev Cancer, 2013, 13 (2) :123-135.
|
|
[7] BALA S, TILAHUN Y, TAHA O, et al.Increased microRNA-155 expression in the serum and periheral monocytes in chronic HCV infection[J].J Transl Med, 2012, 10:151.
|
|
[8] XU MD, LI WYQ, YU HY.Research on microRNA in liver disease and hepatic fibrosis[J].Chin J Pothol, 2011, 40 (1) :65-67. (in Chinese) 许蜜蝶, 利瓦伊卿, 余宏宇.MicroRNA与肝病及肝纤维化相关研究[J].中华病理学志, 2011, 40 (1) :65-67.
|
|
[9]LI BB, MING J, CHEN DG, et al.Recent progress in understanding the role of microRNAs in hepatic stellate cell biology and liver fibrosis pathogenesis[J].J Clin Hepatol, 2013, 29 (5) :380-388. (in Chinese) 李彬彬, 明健, 陈大贵, 等.MicroRNA在肝纤维化进程中的作用[J].临床肝胆病杂志, 2013, 29 (5) :380-388.
|
|
[10]WAIDMANN O, BRUNNER F, ZEUZEM S, et al.Serum MicroRNA-122 predicts survival in patients with liver cirrhosis[J].PLoS One, 2012, 7 (9) :e45652.
|
|
[11]CHEN YJ, ZHU JM, WU H, et al.Circulating microRNAs as a fingerprint for liver cirrhosis[J].PLoS One, 2013, 8 (6) :e66577.
|
|
[12]SHRIVASVATA S, PETRONE J, STEELE R, et al.Up-regulation of circulating miR-20a is correlated with hepatitis C virusmediated liver disease progression[J].Hepatology, 2013, 58 (3) :863-871.
|
|
[13] PADGETT KA, LAN RY, LAN RY, et al.Primary biliary cirrhosis is associated with altered hepatic microRNA expression[J].J Autoimmun, 2009, 32 (3-4) :246-253.
|
|
[14] QIAN Z, WANG HZ, FAN HJ, et al.MicroRNA profiling in T cells of peripheral blood mononuclear cell from patients with primary biliary cirrhosis[J].Natl Med J China, 2012, 92 (32) :2265-2267. (in Chinese) 钱铮, 汪怀周, 范华杰, 等.原发性胆汁性肝硬化患者外周血T细胞microRNA表达谱变化[J].中华医学杂志, 2012, 92 (32) :2265-2267.
|
|
[15]NIOMIYA M, KONDO Y, FUNAYAMA R, et al.Distinct of microRNAs expression profiles in primary biliary cirrhosis and evaluation of miR505-3P and miR197-3P as novel biomarkers[J].PLoS One, 2013, 8 (6) :e66086.
|
|
[16]CERMELLI S, RUGGIERI A, MARRERO JA, et al.Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease[J].PLoS One, 2011, 6 (8) :e23937.
|
|
[17]KRTZFELDT J, RAJEWSKY N, BRAICH R, et al.Silencing of microRNAs in vivo with‘antagomrs’[J].Nature, 2005, 438 (7068) :685-689.
|
|
[18] ESAU C, DAVIS S, MURRAY SF, et al.MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting[J].Cell Metab, 2006, 3 (2) :87-98.
|
|
[19] TRYNDYAK VP, LATENDRESSE JR, MONTGOMERY B, et al.Plasma microRNAs are sensitive indicators of inter-strain differences in the severity of liver injury induced in mice by a cholineand folate-deficient diet[J].Toxicol Appl Pharmacol, 2012, 262 (1) :52-59.
|
|
[20]WANG K, ZHANG S, MARZOLF B, et al.Circulating microRNAs, potential biomarkers for drug-induced liver injury[J].Proc Natl Acad Sci U S A, 2009, 106 (11) :4402-4407.
|
|
[21] STARKEY LEWIS PJ, DEAR J, PLATT V, et al.Circulating microRNAs as potential markers of human drug-induced liver injury[J].Hepatology, 2011, 54 (5) :1767-1776.
|
|
[22]BALA S, PETRASEK J, MUNDKUR S, et al.Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases[J].Hepatology, 2012, 56 (5) :1946-1957.
|
|
[23] MENG F, HENSON R, WEHBE-JANEK H, et al.microRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer[J].Gastroenterology, 2007, 133 (2) :647-658.
|
|
[24] TOMIMARU Y, EGUCHI H, NAGANO H, et al.Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma[J].J Hepatol, 2012, 56 (1) :167-175.
|
|
[25] QU KZ, ZHANG K, LI H, et al.Circulating microRNAs as biomarkers for hepatocellular carcinoma[J].J Clin Gastroenterol, 2011, 45 (4) :355-360.
|
|
[26]AQEILAN RI, CALIN JA, CROCE CM.miR-15a and miR-16-1 in cancer:discovery, function and future perspectives[J].Cell Death Differ, 2010, 17 (2) :215-220.
|
|
[27] GUO CJ, PAN Q, JIANG B, et al.Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells[J].Apoptosis, 2009, 14 (11) :1331-1340.
|
|
[28]ZAHM AM, HAND NJ, BOATENG LA, et al.Circulating microRNA is a biomarker of biliary atresia[J].J Pediatr Gastroenterol Nutr, 2012, 55 (4) :366-369.引证本文:PENG XF, LIU HY.Research advances in circulating miRNAs for diagnosis of hepatobiliary diseases[J].J Clin Hepatol, 2014, 30 (9) :965-968. (in Chinese) 彭小芳, 刘海英.循环miRNA在肝胆疾病诊断中的研究进展[J].临床肝胆病杂志, 2014, 30 (9) :965-968.
|
DownLoad: